US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NANOBIOTIX SPON ADS EACH REP 1 ORD SHS

21.15

-0.6700-3.07%

Post-market: 21.150.00000.00%19:51 EST

Volume:39.77K

Turnover:854.67K

Market Cap:1.02B

PE:-16.53

High:21.86

Open:21.55

Low:21.04

Close:21.82

52wk High:30.35

52wk Low:2.82

Shares:48.24M

Float Shares:24.94M

Volume Ratio:1.57

T/O Rate:0.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2792

EPS(LYR):-1.4924

ROE:--

ROA:-41.64%

PB:-12.70

PE(LYR):-14.17

Loading ...

Overview Company News Filings

Nanobiotix Sa : Leerink Partners Raises Target Price to $26 From $24

THOMSON REUTERS

Nanobiotix Reports €20.4M In Cash And Cash Equivalents As Of Sept. 30

Press Release: Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook

NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations

NANOBIOTIX to Participate in Jefferies London Healthcare Conference

Press Release: NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

Top Premarket Decliners

MT Newswires Live

Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer

Nanobiotix Up Over 25%, on Track for Record High Close -- Data Talk

Stock Track | Nanobiotix (NBTX) Soars 5.07% as Jefferies Triples Price Target

Nanobiotix price target raised to EUR 20 from EUR 13 at H.C. Wainwright

Stock Track | Nanobiotix Surges 16% Pre-Market on Promising Phase 1 Results for Esophageal Cancer Treatment

Stock Track | Nanobiotix Soars 10.83% on Promising Phase 1 Results for JNJ-1900 in Esophageal Cancer Treatment

Stock Track | Nanobiotix (NBTX) Surges 6.51% After-Hours Following Bullish Analyst Rating

Stock Track | Nanobiotix (NBTX) Surges 6.51% After-Hours Following Leerink Partners' Bullish $24 Price Target

Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer

Leerink Partners Sticks to Its Buy Rating for Nanobiotix (NBTX)

Nanobiotix H1 EPS $(0.12) Up From $(0.50) YoY, Sales $30.202M Up From $10.001M YoY

Press Release: NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NBTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NBTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBTX\",,,,,undefined,":{"symbol":"NBTX","market":"US","secType":"STK","nameCN":"NANOBIOTIX SPON ADS EACH REP 1 ORD SHS","latestPrice":21.15,"timestamp":1764968400000,"preClose":21.82,"halted":0,"volume":39774,"hourTrading":{"tag":"盘后","latestPrice":21.15,"preClose":21.15,"latestTime":"19:51 EST","volume":3,"amount":63.45,"timestamp":1764982279078},"delay":0,"floatShares":24937274,"shares":48237471,"eps":-1.279194,"marketStatus":"Market Closed","change":-0.67,"latestTime":"12-05 16:00:00 EST","open":21.55,"high":21.86,"low":21.04,"amount":854669.2803600001,"amplitude":0.03758,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.279194,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":21.82,"preHourTrading":{"tag":"盘前","latestPrice":21.55,"preClose":21.82,"latestTime":"09:28 EST","volume":583,"amount":12617.930214999998,"timestamp":1764944880029},"postHourTrading":{"tag":"盘后","latestPrice":21.15,"preClose":21.15,"latestTime":"19:51 EST","volume":3,"amount":63.45,"timestamp":1764982279078},"volumeRatio":1.5717593879455607},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBTX\",,,,,undefined,":{"symbol":"NBTX","floatShares":24937274,"roa":"-41.64%","roe":"--","lyrEps":-1.492373,"volumeRatio":1.5717593879455607,"shares":48237471,"dividePrice":0,"high":21.86,"amplitude":0.03758,"preClose":21.82,"low":21.04,"week52Low":2.82,"pbRate":"-12.70","psRate":"86.23","week52High":30.35,"institutionHeld":0,"latestPrice":21.15,"eps":-1.279194,"divideRate":0,"volume":39774,"delay":0,"ttmEps":-1.279194,"open":21.55,"prevYearClose":2.87,"prevWeekClose":20.69,"prevMonthClose":20.69,"prevQuarterClose":18.89,"fiveDayClose":20.69,"twentyDayClose":19.67,"sixtyDayClose":9.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-24","symbol":"NBTX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763960400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-09-30","symbol":"NBTX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1759204800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-21","symbol":"NBTX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747800000000,"reportTimeType":"post","actualEps":null},{"date":"2025-04-02","symbol":"NBTX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1743624000000,"name":null,"time":"Post Market","dateTimestamp":1743566400000,"actualEps":null},{"date":"2024-11-12","symbol":"NBTX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1731402000000,"name":null,"time":"Pre-Market","dateTimestamp":1731387600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.7143,"buy":0.1429,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.7143,"analysts":7,"updateTime":1743483600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBTX","date":"2025-12-05","current":-16.533849,"percent":0.032815,"low":-22.826874,"twenty":-6.073243,"median":-4.927558,"eighty":-4.093904,"high":-1.979488,"avg":-5.845351,"sd":3.743606,"marketCap":1027844492.13},"quantilePoints":[{"date":"2023-07-14","current":-3.501201,"twenty":-3.535419,"median":-3.522587,"eighty":-3.509755,"marketCap":223541537.94},{"date":"2023-07-21","current":-4.607165,"twenty":-4.211217,"median":-3.916701,"eighty":-3.561082,"marketCap":292908275.75},{"date":"2023-07-28","current":-4.472424,"twenty":-4.908851,"median":-4.368706,"eighty":-3.686954,"marketCap":280373135.51},{"date":"2023-08-04","current":-4.167347,"twenty":-4.820211,"median":-4.216168,"eighty":-3.916701,"marketCap":260275527.21},{"date":"2023-08-11","current":-5.137491,"twenty":-4.838516,"median":-4.448017,"eighty":-3.996135,"marketCap":322810760.08},{"date":"2023-08-18","current":-4.740891,"twenty":-4.85682,"median":-4.484627,"eighty":-4.088027,"marketCap":294164220.6},{"date":"2023-08-25","current":-5.979502,"twenty":-5.11432,"median":-4.740891,"eighty":-4.136839,"marketCap":369410580.53},{"date":"2023-09-01","current":-5.167998,"twenty":-5.222912,"median":-4.829363,"eighty":-4.167347,"marketCap":319726459.87},{"date":"2023-09-08","current":-5.481134,"twenty":-5.430364,"median":-4.85377,"eighty":-4.24546,"marketCap":334563278.76},{"date":"2023-09-15","current":-5.474962,"twenty":-5.525576,"median":-5.003257,"eighty":-4.299143,"marketCap":333117121.07},{"date":"2023-09-22","current":-5.148636,"twenty":-5.489775,"median":-5.033765,"eighty":-4.41995,"marketCap":313162034.55},{"date":"2023-09-29","current":-5.106809,"twenty":-5.476196,"median":-5.064272,"eighty":-4.452899,"marketCap":317195243.03},{"date":"2023-10-06","current":-3.91317,"twenty":-5.458808,"median":-5.082465,"eighty":-4.440723,"marketCap":242185565.38},{"date":"2023-10-13","current":-3.790114,"twenty":-5.430364,"median":-5.003257,"eighty":-4.161245,"marketCap":235064644.44},{"date":"2023-10-20","current":-3.53785,"twenty":-5.37545,"median":-4.917201,"eighty":-3.980248,"marketCap":219952860.92},{"date":"2023-10-27","current":-3.593225,"twenty":-5.352028,"median":-4.890347,"eighty":-3.913876,"marketCap":222431066.76},{"date":"2023-11-03","current":-3.568614,"twenty":-5.301288,"median":-4.850719,"eighty":-3.84795,"marketCap":222689835.46},{"date":"2023-11-10","current":-4.213554,"twenty":-5.270695,"median":-4.81716,"eighty":-3.860256,"marketCap":265329783.61},{"date":"2023-11-17","current":-4.362915,"twenty":-5.238319,"median":-4.607165,"eighty":-3.876253,"marketCap":278584883.77},{"date":"2023-11-24","current":-4.166387,"twenty":-5.222912,"median":-4.472424,"eighty":-3.900864,"marketCap":267080431.84},{"date":"2023-12-01","current":-4.024888,"twenty":-5.218195,"median":-4.451068,"eighty":-3.91317,"marketCap":258037914.71},{"date":"2023-12-08","current":-4.087358,"twenty":-5.173999,"median":-4.362915,"eighty":-3.916701,"marketCap":259215849.61},{"date":"2023-12-15","current":-4.34382,"twenty":-5.167998,"median":-4.350062,"eighty":-3.926624,"marketCap":280750695.99},{"date":"2023-12-22","current":-4.61631,"twenty":-5.148636,"median":-4.362915,"eighty":-3.938415,"marketCap":298296767.07},{"date":"2023-12-29","current":-5.32158,"twenty":-5.156381,"median":-4.395914,"eighty":-3.945691,"marketCap":346498043.86},{"date":"2024-01-05","current":-5.682229,"twenty":-5.209356,"median":-4.411545,"eighty":-3.95755,"marketCap":366047647.12},{"date":"2024-01-12","current":-5.618114,"twenty":-5.287183,"median":-4.459615,"eighty":-3.987504,"marketCap":361560742.28},{"date":"2024-01-19","current":-5.409739,"twenty":-5.363247,"median":-4.484627,"eighty":-3.995192,"marketCap":345502680.36},{"date":"2024-01-26","current":-5.746345,"twenty":-5.441796,"median":-4.512123,"eighty":-3.996135,"marketCap":366085807.95},{"date":"2024-02-02","current":-5.562013,"twenty":-5.524341,"median":-4.6786,"eighty":-4.024888,"marketCap":354688432.41},{"date":"2024-02-09","current":-5.545984,"twenty":-5.530514,"median":-4.814109,"eighty":-4.024888,"marketCap":350925266.95},{"date":"2024-02-16","current":-5.545984,"twenty":-5.545984,"median":-4.844618,"eighty":-4.063315,"marketCap":350736495.97},{"date":"2024-02-23","current":-5.001003,"twenty":-5.545984,"median":-4.864912,"eighty":-4.081021,"marketCap":317981557.6},{"date":"2024-03-01","current":-4.76057,"twenty":-5.545984,"median":-4.85682,"eighty":-4.086976,"marketCap":302497661.87},{"date":"2024-03-08","current":-4.720498,"twenty":-5.539572,"median":-4.839615,"eighty":-4.087893,"marketCap":303262323.5},{"date":"2024-03-15","current":-4.448007,"twenty":-5.532005,"median":-4.820211,"eighty":-4.093904,"marketCap":284791651.24},{"date":"2024-03-22","current":-4.624325,"twenty":-5.530067,"median":-4.776599,"eighty":-4.108163,"marketCap":295180454.99},{"date":"2024-03-28","current":-4.568224,"twenty":-5.526587,"median":-4.746723,"eighty":-4.116194,"marketCap":290056056.38},{"date":"2024-04-05","current":-4.576238,"twenty":-5.498417,"median":-4.720498,"eighty":-4.124016,"marketCap":292206179.67},{"date":"2024-04-12","current":-4.19956,"twenty":-5.477431,"median":-4.692448,"eighty":-4.1321,"marketCap":264391924.6},{"date":"2024-04-19","current":-4.207575,"twenty":-5.462847,"median":-4.640354,"eighty":-4.136281,"marketCap":263738379.19},{"date":"2024-04-26","current":-6.467408,"twenty":-5.477431,"median":-4.63234,"eighty":-4.150428,"marketCap":275046699.52},{"date":"2024-05-03","current":-6.97768,"twenty":-5.533496,"median":-4.68844,"eighty":-4.161892,"marketCap":296366656.68},{"date":"2024-05-10","current":-7.559154,"twenty":-5.552396,"median":-4.712483,"eighty":-4.16523,"marketCap":323347060.66},{"date":"2024-05-17","current":-8.027893,"twenty":-5.579986,"median":-4.740891,"eighty":-4.166963,"marketCap":346421016.3},{"date":"2024-05-24","current":-7.262484,"twenty":-5.611631,"median":-4.776599,"eighty":-4.16744,"marketCap":312069060.5},{"date":"2024-05-31","current":-7.701555,"twenty":-5.672612,"median":-4.81716,"eighty":-4.178722,"marketCap":331546033.4},{"date":"2024-06-07","current":-6.236005,"twenty":-5.710545,"median":-4.838516,"eighty":-4.197156,"marketCap":269389997.82},{"date":"2024-06-14","current":-5.007791,"twenty":-5.743958,"median":-4.85377,"eighty":-4.202043,"marketCap":214003558.67},{"date":"2024-06-21","current":-4.701628,"twenty":-5.735439,"median":-4.85377,"eighty":-4.206129,"marketCap":200015660.09},{"date":"2024-06-28","current":-5.280728,"twenty":-5.730501,"median":-4.85682,"eighty":-4.206491,"marketCap":224435161.12},{"date":"2024-07-05","current":-5.791,"twenty":-5.768785,"median":-4.872772,"eighty":-4.208771,"marketCap":248543463.78},{"date":"2024-07-12","current":-5.948876,"twenty":-5.790083,"median":-4.896815,"eighty":-4.218271,"marketCap":256734839.66},{"date":"2024-07-15","current":-5.803199,"twenty":-5.798319,"median":-4.896815,"eighty":-4.222987,"marketCap":251459290.55},{"date":"2024-08-02","current":-5.528562,"twenty":-5.79588,"median":-4.902252,"eighty":-4.227704,"marketCap":236716903.58},{"date":"2024-08-09","current":-5.218103,"twenty":-5.78825,"median":-4.912857,"eighty":-4.250846,"marketCap":226007727.47},{"date":"2024-08-16","current":-5.385273,"twenty":-5.782047,"median":-4.966007,"eighty":-4.262987,"marketCap":234836714.63},{"date":"2024-08-23","current":-5.624088,"twenty":-5.773886,"median":-5.003257,"eighty":-4.271861,"marketCap":248002101.52},{"date":"2024-08-30","current":-5.951264,"twenty":-5.78825,"median":-5.02715,"eighty":-4.280804,"marketCap":261702690.52},{"date":"2024-09-06","current":-5.318405,"twenty":-5.783503,"median":-5.082465,"eighty":-4.2933,"marketCap":234080576.5},{"date":"2024-09-13","current":-5.20855,"twenty":-5.775635,"median":-5.106809,"eighty":-4.309314,"marketCap":228183011.48},{"date":"2024-09-20","current":-6.387098,"twenty":-5.783503,"median":-5.121967,"eighty":-4.313357,"marketCap":238132484.96},{"date":"2024-09-27","current":-6.610859,"twenty":-5.823638,"median":-5.137491,"eighty":-4.320566,"marketCap":247329041.02},{"date":"2024-10-04","current":-6.622189,"twenty":-5.911442,"median":-5.170998,"eighty":-4.334203,"marketCap":244150821.68},{"date":"2024-10-11","current":-6.262472,"twenty":-5.933402,"median":-5.182281,"eighty":-4.345169,"marketCap":229021882.44},{"date":"2024-10-18","current":-6.344612,"twenty":-5.96344,"median":-5.207356,"eighty":-4.349488,"marketCap":229965569.03},{"date":"2024-10-25","current":-5.891426,"twenty":-6.017528,"median":-5.218103,"eighty":-4.356925,"marketCap":213008953.34},{"date":"2024-10-31","current":-5.57986,"twenty":-5.977675,"median":-5.222912,"eighty":-4.362915,"marketCap":202795491.86},{"date":"2024-11-08","current":-5.599687,"twenty":-5.970096,"median":-5.248048,"eighty":-4.36711,"marketCap":202177018.66},{"date":"2024-11-15","current":-5.200316,"twenty":-5.966221,"median":-5.253925,"eighty":-4.388701,"marketCap":184162271.48},{"date":"2024-11-22","current":-4.956728,"twenty":-5.95433,"median":-5.236108,"eighty":-4.408657,"marketCap":174044440.37},{"date":"2024-11-29","current":-4.2203,"twenty":-5.951264,"median":-5.220553,"eighty":-4.390245,"marketCap":149030598.16},{"date":"2024-12-06","current":-4.381748,"twenty":-5.948876,"median":-5.208813,"eighty":-4.362915,"marketCap":155026152.63},{"date":"2024-12-13","current":-4.565855,"twenty":-5.948074,"median":-5.207356,"eighty":-4.362915,"marketCap":160302977.76},{"date":"2024-12-20","current":-4.534698,"twenty":-5.933402,"median":-5.191833,"eighty":-4.378915,"marketCap":157589239},{"date":"2024-12-27","current":-4.342094,"twenty":-5.933402,"median":-5.179892,"eighty":-4.351783,"marketCap":151367330.76},{"date":"2025-01-03","current":-4.262786,"twenty":-5.933402,"median":-5.167998,"eighty":-4.34313,"marketCap":146331910.57},{"date":"2025-01-10","current":-4.206138,"twenty":-5.933402,"median":-5.137491,"eighty":-4.320566,"marketCap":144937262.71},{"date":"2025-01-17","current":-4.296775,"twenty":-5.9259,"median":-5.121967,"eighty":-4.288937,"marketCap":148060488.98},{"date":"2025-01-24","current":-4.789616,"twenty":-5.913045,"median":-5.106809,"eighty":-4.298956,"marketCap":166915988.55},{"date":"2025-01-31","current":-4.956728,"twenty":-5.905291,"median":-5.100657,"eighty":-4.308498,"marketCap":172955868.86},{"date":"2025-02-07","current":-5.480725,"twenty":-5.898224,"median":-5.082771,"eighty":-4.312559,"marketCap":190346872.8},{"date":"2025-02-14","current":-5.509049,"twenty":-5.889516,"median":-5.104251,"eighty":-4.318157,"marketCap":192589463.19},{"date":"2025-02-21","current":-5.101181,"twenty":-5.881878,"median":-5.101181,"eighty":-4.327791,"marketCap":178685483.47},{"date":"2025-02-28","current":-4.905745,"twenty":-5.862201,"median":-5.100919,"eighty":-4.342094,"marketCap":170874084.29},{"date":"2025-03-07","current":-4.367586,"twenty":-5.827081,"median":-5.070025,"eighty":-4.34382,"marketCap":158323799},{"date":"2025-03-14","current":-4.174981,"twenty":-5.818474,"median":-5.054777,"eighty":-4.311762,"marketCap":151818741.99},{"date":"2025-03-21","current":-4.803778,"twenty":-5.803199,"median":-5.038868,"eighty":-4.311762,"marketCap":174475753.04},{"date":"2025-03-28","current":-4.860426,"twenty":-5.791,"median":-5.008404,"eighty":-4.315749,"marketCap":175618569.73},{"date":"2025-04-04","current":-2.056719,"twenty":-5.786417,"median":-5.001003,"eighty":-4.311762,"marketCap":155112231.57},{"date":"2025-04-11","current":-2.052545,"twenty":-5.779133,"median":-4.956728,"eighty":-4.282613,"marketCap":156407518.17},{"date":"2025-04-17","current":-2.087333,"twenty":-5.772137,"median":-4.943869,"eighty":-4.262226,"marketCap":161717306.12},{"date":"2025-04-25","current":-1.989924,"twenty":-5.763976,"median":-4.926712,"eighty":-4.244659,"marketCap":153942927.22},{"date":"2025-05-02","current":-2.118643,"twenty":-5.749551,"median":-4.912127,"eighty":-4.234462,"marketCap":162773354.76},{"date":"2025-05-09","current":-2.146475,"twenty":-5.741571,"median":-4.90769,"eighty":-4.212358,"marketCap":164892999.21},{"date":"2025-05-16","current":-2.44218,"twenty":-5.720625,"median":-4.897032,"eighty":-4.198759,"marketCap":186119252.8},{"date":"2025-05-23","current":-2.334335,"twenty":-5.714567,"median":-4.885918,"eighty":-4.177247,"marketCap":179445874.99},{"date":"2025-05-30","current":-2.553505,"twenty":-5.713505,"median":-4.872772,"eighty":-4.166963,"marketCap":197676820.82},{"date":"2025-06-06","current":-2.890957,"twenty":-5.708153,"median":-4.857931,"eighty":-4.161892,"marketCap":225542957.75},{"date":"2025-06-13","current":-3.092732,"twenty":-5.69612,"median":-4.850719,"eighty":-4.1321,"marketCap":243881988.43},{"date":"2025-06-20","current":-2.699618,"twenty":-5.68801,"median":-4.838516,"eighty":-4.114582,"marketCap":210929316.51},{"date":"2025-06-27","current":-2.772675,"twenty":-5.683687,"median":-4.828393,"eighty":-4.086212,"marketCap":220996561.77},{"date":"2025-07-03","current":-2.998802,"twenty":-5.682229,"median":-4.820253,"eighty":-4.024888,"marketCap":240313336.86},{"date":"2025-07-11","current":-3.096211,"twenty":-5.67742,"median":-4.815107,"eighty":-3.983018,"marketCap":246553367.23},{"date":"2025-07-18","current":-3.155352,"twenty":-5.656583,"median":-4.808943,"eighty":-3.94084,"marketCap":249137170.01},{"date":"2025-07-25","current":-4.000722,"twenty":-5.649856,"median":-4.789616,"eighty":-3.913876,"marketCap":320830054.14},{"date":"2025-08-01","current":-4.135731,"twenty":-5.643696,"median":-4.785367,"eighty":-3.918686,"marketCap":322324017.39},{"date":"2025-08-08","current":-4.466309,"twenty":-5.62374,"median":-4.76057,"eighty":-3.928982,"marketCap":353917818.1},{"date":"2025-08-15","current":-4.853154,"twenty":-5.6215,"median":-4.764661,"eighty":-3.94084,"marketCap":385244211.81},{"date":"2025-08-22","current":-5.922255,"twenty":-5.62374,"median":-4.783951,"eighty":-3.951811,"marketCap":468580968.53},{"date":"2025-08-29","current":-5.555161,"twenty":-5.6215,"median":-4.789616,"eighty":-3.957303,"marketCap":441381039.07},{"date":"2025-09-05","current":-5.09518,"twenty":-5.618114,"median":-4.798203,"eighty":-3.958976,"marketCap":404079596.09},{"date":"2025-09-12","current":-5.923146,"twenty":-5.624088,"median":-4.815107,"eighty":-3.965383,"marketCap":473935182.62},{"date":"2025-09-19","current":-6.913876,"twenty":-5.658186,"median":-4.817659,"eighty":-3.982377,"marketCap":555228880.25},{"date":"2025-09-26","current":-9.312875,"twenty":-5.690244,"median":-4.824685,"eighty":-3.985582,"marketCap":740811246.94},{"date":"2025-10-03","current":-15.871446,"twenty":-5.715687,"median":-4.836725,"eighty":-3.995192,"marketCap":958990407.16},{"date":"2025-10-10","current":-20.912965,"twenty":-5.770388,"median":-4.850719,"eighty":-3.996135,"marketCap":1248853176.46},{"date":"2025-10-17","current":-20.819603,"twenty":-5.803199,"median":-4.857207,"eighty":-4.000722,"marketCap":1254886509.1},{"date":"2025-10-24","current":-15.049866,"twenty":-5.830819,"median":-4.860426,"eighty":-4.024888,"marketCap":902170871.74},{"date":"2025-10-31","current":-16.711942,"twenty":-5.899923,"median":-4.873629,"eighty":-4.024888,"marketCap":997981981.96},{"date":"2025-11-07","current":-15.890349,"twenty":-5.923146,"median":-4.896815,"eighty":-4.063315,"marketCap":946729704.66},{"date":"2025-11-14","current":-16.973358,"twenty":-5.933402,"median":-4.901497,"eighty":-4.085448,"marketCap":1020436690.34},{"date":"2025-11-21","current":-16.99203,"twenty":-5.955096,"median":-4.91141,"eighty":-4.087358,"marketCap":1012600304.64},{"date":"2025-11-28","current":-16.207783,"twenty":-5.985215,"median":-4.912844,"eighty":-4.087893,"marketCap":970793931.8},{"date":"2025-12-05","current":-17.066721,"twenty":-6.073243,"median":-4.927558,"eighty":-4.093904,"marketCap":1027844492.13}],"updateTime":1765143345431},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586468324","title":"Nanobiotix Sa : Leerink Partners Raises Target Price to $26 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2586468324","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586468324?lang=en_us&edition=fundamental","pubTime":"2025-11-25 12:46","pubTimestamp":1764046001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X00IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NBTX","BK4139"],"gpt_icon":0},{"id":"2586901934","title":"Nanobiotix Reports €20.4M In Cash And Cash Equivalents As Of Sept. 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2586901934","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586901934?lang=en_us&edition=fundamental","pubTime":"2025-11-25 05:16","pubTimestamp":1764019008,"startTime":"0","endTime":"0","summary":"Nanobiotix Reports €20.4M In Cash And Cash Equivalents As Of Sept. 30","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/49045096/nanobiotix-reports-20-4m-in-cash-and-cash-equivalents-as-of-sept-30","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nanobiotix Reports €20.4M In Cash And Cash Equivalents As Of Sept. 30","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBTX","BK4139"],"gpt_icon":0},{"id":"2586349013","title":"Press Release: Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2586349013","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586349013?lang=en_us&edition=fundamental","pubTime":"2025-11-25 05:15","pubTimestamp":1764018900,"startTime":"0","endTime":"0","summary":"-- Financial foundation toward self-sustained long-term growth established. with the closing with HealthCare Royalty  of a non-dilutive. -- Progress in the JNJ-1900  global development program announced. including first data from a Phase 1 esophageal cancer study sponsored by. The University of Texas MD Anderson Cancer Center . -- Completed the NANORAY-312 sponsorship transfer to Johnson & Johnson in. -- Advanced the Curadigm Nanoprimer program with updated plans for internal. -- Clinical updates from ongoing or completed JNJ-1900  Phase 1. studies sponsored by Nanobiotix or MD Anderson in melanoma, lung cancer. amenable to re-irradiation, pancreatic cancer, and esophageal cancer. -- Establishing the Financial Foundation for Self-sustained Long-term Growth. -- Closed the royalty financing transaction with Healthcare Royalty. -- Nanobiotix expects to receive an additional $21 million in one. -- Presented first data from a Phase 1 MD Anderson study evaluating. the 2025 Annual Meeting of ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","IE00B4R5TH58.HKD","BK4532","LU0882574139.USD","LU0289739699.SGD","LU2065170008.USD","LU2129689605.HKD","JNJ","BK4533","LU2237443622.USD","LU2237443978.SGD","IE00BJT1NW94.SGD","BK4534","LU1119994496.HKD","SG9999001440.SGD","LU2237443895.HKD","LU1221951046.USD","LU1894683348.USD","LU1066053197.SGD","LU0640476718.USD","LU1929549753.HKD","LU1059921491.USD","LU0985320562.USD","LU1221951129.SGD","CMC","BK4592","PODD","IE0034235303.USD","SG9999002224.SGD","BK4581","IE00B7SZLL34.SGD","LU0792757196.USD","LU0058720904.USD","BK4139","LU0466842654.USD","LU1023059063.AUD","LU2237443549.SGD","LU1066051811.HKD","LU1196500208.SGD","LU0889566641.SGD","LU1066051498.USD","LU0149725797.USD","LU1244550494.USD","LU2089984988.USD","NBTX","IE00BDGV0183.EUR","LU2468319806.SGD","IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","LU1162221912.USD"],"gpt_icon":0},{"id":"2583554894","title":"NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations","url":"https://stock-news.laohu8.com/highlight/detail?id=2583554894","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583554894?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:15","pubTimestamp":1763068500,"startTime":"0","endTime":"0","summary":"Four new patent applications filed that aim to expand the Curadigm Nanoprimer platform intellectual property portfolio and support an initial proprietary internal pipeline of Nanoprimer products in ad","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187870/0/en/NANOBIOTIX-Announces-Curadigm-Nanoprimer-Platform-Advancements-With-Updated-Plans-for-Internal-Pipeline-Development-and-External-Collaborations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2237443895.HKD","LU1261432733.SGD","IE00BHPRN162.USD","BK4156","BK4588","NBTX","BK4139","LU2065171402.SGD","LU2065169927.USD","LU1084165304.USD","LU2237443978.SGD","LU0971096721.USD","IE00B1BXHZ80.USD","LU2065170008.USD","LU2237443382.USD","LU2237443465.HKD","LU0728928796.USD","BK4551","LU0882574139.USD","LU2746668974.SGD","LU2746668461.USD","CMC","LU1119994496.HKD","LU2324357040.USD","IE00BZ1G4Q59.USD","LU2237443549.SGD","BK4585","LU0149725797.USD","LU0267386448.USD","LU2237443622.USD","IE00BFXG1179.USD","IE00BKVL7J92.USD","LU2065171311.SGD","BK4006","LU0170899867.USD","BK4566","LU1363072403.SGD","PODD"],"gpt_icon":0},{"id":"2582390235","title":"NANOBIOTIX to Participate in Jefferies London Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2582390235","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582390235?lang=en_us&edition=fundamental","pubTime":"2025-11-12 05:15","pubTimestamp":1762895700,"startTime":"0","endTime":"0","summary":"PARIS and CAMBRIDGE, Mass., Nov.  11, 2025  (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic appro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/11/3185783/0/en/NANOBIOTIX-to-Participate-in-Jefferies-London-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","BK4581","LABU","LU0029874061.USD","BK4588","BK4137","NBTX","BK4139","XBI","HCSG","BK4156","BK4585","XLV"],"gpt_icon":0},{"id":"2579434453","title":"Press Release: NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2579434453","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579434453?lang=en_us&edition=fundamental","pubTime":"2025-10-31 15:00","pubTimestamp":1761894000,"startTime":"0","endTime":"0","summary":"-- $71 million in funding would extend Nanobiotix cash visibility into early. -- Transaction enables Nanobiotix development beyond key milestones in head. -- Financing establishes financial foundation toward self-sustainability and. the advancement of next wave nanotherapeutic platforms for long-term. \"This non-dilutive financing reflects our commitment to preserving long-term shareholder value, while strategically aligning capital to unlock the full potential of our nanotherapeutics platforms. Importantly, this funding provides the resources to advance the company through critical potential milestones that will lead to self-sustainability and durable value creation,\" said Bart van Rhijn, Chief Financial and Business Officer at Nanobiotix.-- At the closing of the agreement, Nanobiotix will receive an upfront. -- Repayment from a defined portion of royalties on the first $1. -- Following achievement of the Return Cap, a royalty-only tail. share of royalties not to exceed $14.9 million p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","IE00B4R5TH58.HKD","LU0345770308.USD","LU1057294990.SGD","BK4232","LU0130102774.USD","LU1244550221.USD","IE00B2B36J28.USD","JNJ","LU0795875086.SGD","IE000M9KFDE8.USD","LU1718418525.SGD","LU2133065610.SGD","KKR","BK4559","LU1221951046.USD","LU0314104364.USD","R","XBI","LU0029874061.USD","BK4592","XLV","IE0034235303.USD","LU1066051225.USD","IE00BLSP4452.SGD","LU0792757196.USD","IE00B64PRP62.GBP","LU1023059063.AUD","LU0466842654.USD","LU0795875169.SGD","LU2750360997.AUD","LU1066051811.HKD","LABU","LU1267930813.SGD","LU1668664300.SGD","LU1914381329.SGD","NBTX","IE00BSNM7G36.USD","LU0203345920.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU1778281490.HKD","LU1506573853.SGD","LU0106831901.USD","HCSG","LU0098860793.USD","IE00B3PB1722.GBP","LU1261432733.SGD","LU1061106388.HKD","LU1430594728.SGD"],"gpt_icon":0},{"id":"2578643736","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2578643736","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578643736?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:53","pubTimestamp":1761566004,"startTime":"0","endTime":"0","summary":"Genenta Science  shares were nearly 35% lower pre-bell Monday after the company priced overnight a $15 million registered direct offering of American depositary shares.MaxsMaking  stock was down 23%, paring gains from the previous session.United States Antimony  shares were 15% lower after Friday's 2.4% gain.Nanobiotix  stock was down 12% following a largely muted session Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UAMY","BK4168","GNTA","BK4139","NBTX","MAMK","BK4202"],"gpt_icon":1},{"id":"2577599969","title":"Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer","url":"https://stock-news.laohu8.com/highlight/detail?id=2577599969","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577599969?lang=en_us&edition=fundamental","pubTime":"2025-10-24 17:15","pubTimestamp":1761297322,"startTime":"0","endTime":"0","summary":"Nanobiotix (NBTX) announced updates to the JNJ-1900 clinical development program. Nanobiotix has completed the transfer of NANORAY-312 sponsorship,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanobiotix-provides-update-on-jnj-1900-after-johnson-johnson-transfer-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanobiotix-provides-update-on-jnj-1900-after-johnson-johnson-transfer-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889566641.SGD","BK4532","LU1221951129.SGD","SG9999001440.SGD","LU2347655156.SGD","LU0985320562.USD","BK4534","LU1162221912.USD","BK4559","LU1430594728.SGD","LU0114720955.EUR","LU1929549753.HKD","BK4139","LU0432979614.USD","LU2592432038.USD","LU2129689605.HKD","LU2129689514.USD","LU0234570918.USD","LU0640476718.USD","NBTX","LU2089984988.USD","BK4533","LU0792757196.USD","LU1732800096.USD","IE00BFXG1179.USD","JNJ","SG9999002224.SGD","BK4568","LU1778281490.HKD","IE00BLSP4452.SGD","LU0203347892.USD","LU1066051811.HKD","LU0289739699.SGD","LU0345770308.USD","IE000M9KFDE8.USD","IE00B1BXHZ80.USD","LU1057294990.SGD","LU1506573853.SGD","LU2505996681.GBP","LU2468319806.SGD","LU1894683264.USD","LU0912757837.SGD","LU1935042991.SGD","LU2471134523.USD","LU0882574055.USD","LU2750360641.GBP","LU1894683348.USD","LU1267930813.SGD","LU2430703251.USD","IE00BVYPNV92.GBP"],"gpt_icon":0},{"id":"2573518922","title":"Nanobiotix Up Over 25%, on Track for Record High Close -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2573518922","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573518922?lang=en_us&edition=fundamental","pubTime":"2025-10-08 22:50","pubTimestamp":1759935000,"startTime":"0","endTime":"0","summary":"Nanobiotix SA Sponsored ADR  is currently at $26.31, up $5.34 or 25.46%. --On pace for largest percent increase since May 5, 2023, when it rose 229.05%. --Up 816.72% year-to-date; on pace for best year on record . --Up 420.99% from 52 weeks ago , when it closed at $5.05. --Traded as high as $26.70; new all-time intraday high . --Up 27.35% at today's intraday high; largest intraday percent increase since Sept. 18, 2025, when it rose as much as 29.38%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NBTX"],"gpt_icon":0},{"id":"1176581307","title":"Stock Track | Nanobiotix (NBTX) Soars 5.07% as Jefferies Triples Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1176581307","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176581307?lang=en_us&edition=fundamental","pubTime":"2025-10-06 22:02","pubTimestamp":1759759338,"startTime":"0","endTime":"0","summary":"Shares of Nanobiotix (NASDAQ: NBTX), a biotechnology company, are soaring 5.07% in pre-market trading on Monday. The stock's upward movement comes on the heels of a significant price target upgrade...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NBTX"],"gpt_icon":0},{"id":"2572164835","title":"Nanobiotix price target raised to EUR 20 from EUR 13 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2572164835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572164835?lang=en_us&edition=fundamental","pubTime":"2025-10-02 18:35","pubTimestamp":1759401334,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Nanobiotix (NBTX) to EUR 20 from EUR 13 and keeps a Buy rating on the shares after the company pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanobiotix-price-target-raised-to-eur-20-from-eur-13-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanobiotix-price-target-raised-to-eur-20-from-eur-13-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBTX","BK4139"],"gpt_icon":0},{"id":"1173367773","title":"Stock Track | Nanobiotix Surges 16% Pre-Market on Promising Phase 1 Results for Esophageal Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1173367773","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173367773?lang=en_us&edition=fundamental","pubTime":"2025-10-02 16:04","pubTimestamp":1759392263,"startTime":"0","endTime":"0","summary":"Shares of Nanobiotix (NBTX), a late-stage clinical biotechnology company, soared 16.06% in pre-market trading on Thursday, following the announcement of encouraging early results from a Phase 1 study...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NBTX"],"gpt_icon":0},{"id":"1178528278","title":"Stock Track | Nanobiotix Soars 10.83% on Promising Phase 1 Results for JNJ-1900 in Esophageal Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1178528278","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178528278?lang=en_us&edition=fundamental","pubTime":"2025-10-02 15:08","pubTimestamp":1759388912,"startTime":"0","endTime":"0","summary":"Shares of Nanobiotix (NBTX) surged 10.83% in Thursday's trading session following the announcement of encouraging early results from a Phase 1 study evaluating JNJ-1900 (NBTXR3) in patients with...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NBTX"],"gpt_icon":0},{"id":"1110233152","title":"Stock Track | Nanobiotix (NBTX) Surges 6.51% After-Hours Following Bullish Analyst Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1110233152","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110233152?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:32","pubTimestamp":1759350736,"startTime":"0","endTime":"0","summary":"Shares of Nanobiotix (NBTX), a biotechnology company, soared 6.51% in after-hours trading on Wednesday, following a bullish analyst report earlier in the day. The stock's upward movement came as...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NBTX"],"gpt_icon":0},{"id":"1168961084","title":"Stock Track | Nanobiotix (NBTX) Surges 6.51% After-Hours Following Leerink Partners' Bullish $24 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1168961084","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168961084?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:32","pubTimestamp":1759350735,"startTime":"0","endTime":"0","summary":"Shares of Nanobiotix (NBTX), a biotechnology company, soared 6.51% in after-hours trading on Wednesday, building on positive sentiment from a bullish analyst report. The stock's movement comes as...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NBTX"],"gpt_icon":0},{"id":"2572550688","title":"Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts","url":"https://stock-news.laohu8.com/highlight/detail?id=2572550688","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572550688?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:25","pubTimestamp":1759350338,"startTime":"0","endTime":"0","summary":"Nanobiotix (NBTX) announced first data from cohorts 1 and 2 of the dose escalation part of a Phase 1 dose escalation and dose expansion study evalu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanobiotix-presents-data-from-jnj-1900-dose-escalation-expansion-study-cohorts-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanobiotix-presents-data-from-jnj-1900-dose-escalation-expansion-study-cohorts-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","IE0034235303.USD","IE00BLSP4452.SGD","IE00BVYPNV92.GBP","IE00BVYPNW00.USD","LU1066051811.HKD","LU0203347892.USD","LU0234570918.USD","LU1032466523.USD","IE00B3T34201.USD","LU1221951046.USD","LU1732800096.USD","LU2750360997.AUD","LU2750360641.GBP","SG9999001440.SGD","LU1894683264.USD","BK4581","LU0466842654.USD","BK4568","LU1935042991.SGD","LU2430703251.USD","LU1061106388.HKD","LU0203345920.USD","LU1059921491.USD","LU0289739699.SGD","LU1066051225.USD","LU2347655156.SGD","LU0985320562.USD","LU1914381329.SGD","LU1261432733.SGD","LU2471134952.CNY","LU2592432038.USD","LU1674673428.USD","LU1506573853.SGD","LU0114720955.EUR","IE00B1BXHZ80.USD","LU0345770993.USD","LU1585245621.USD","LU2505996681.GBP","LU1057294990.SGD","LU2505996509.AUD","LU1894683348.USD","JNJ","LU1674673691.USD","LU0234572021.USD","IE00BDGV0183.EUR","IE00BLSP4239.USD","LU1244550494.USD","LU0098860793.USD","NBTX"],"gpt_icon":0},{"id":"2572255031","title":"NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2572255031","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572255031?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:15","pubTimestamp":1759349700,"startTime":"0","endTime":"0","summary":"Treatment was well-tolerated and injection feasibility was confirmed in 13 patients with locally advanced adenocarcinoma of the esophagus85% (11/13) disease control rate (DCR)69% (9/13) objective resp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/01/3159946/0/en/NANOBIOTIX-Announces-First-Data-From-Phase-1-Study-Evaluating-JNJ-1900-NBTXR3-for-Patients-With-Esophageal-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","IE0002141913.USD","IE00BBT3K403.USD","IE00B2B36J28.USD","LU1674673691.USD","LU1244550494.USD","LU1894683348.USD","LU2430703178.SGD","LU2505996681.GBP","BK4581","LU1732800096.USD","LU2592432038.USD","LU2471134952.CNY","LU0203345920.USD","IE00B7SZLL34.SGD","LU2430703251.USD","LU2471134879.HKD","ORR","IE00B3T34201.USD","IE00BN8TJ469.HKD","LU1929549753.HKD","LU0432979614.USD","LU0098860793.USD","LU1059921491.USD","LU1162221912.USD","NBTX","LU0070217475.USD","LU1778281490.HKD","LU1935042991.SGD","LU0466842654.USD","IE00BGHQF631.EUR","LU1261432733.SGD","LU1066051225.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU1057294990.SGD","IE00BVYPNW00.USD","LU2505996509.AUD","LU1718418525.SGD","BK4007","LU2112291526.USD","LU2133065610.SGD","JNJ","LU1196500208.SGD","LU2430703095.HKD","LU1066051811.HKD","LU1032466523.USD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2572353960","title":"Leerink Partners Sticks to Its Buy Rating for Nanobiotix (NBTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572353960","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572353960?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:15","pubTimestamp":1759320938,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Jonathan Chang maintained a Buy rating on Nanobiotix today and set a price target of $24.00. The company’s shares closed y...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/leerink-partners-sticks-to-its-buy-rating-for-nanobiotix-nbtx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/leerink-partners-sticks-to-its-buy-rating-for-nanobiotix-nbtx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBTX"],"gpt_icon":0},{"id":"2572374598","title":"Nanobiotix H1 EPS $(0.12) Up From $(0.50) YoY, Sales $30.202M Up From $10.001M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2572374598","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572374598?lang=en_us&edition=fundamental","pubTime":"2025-10-01 04:36","pubTimestamp":1759264578,"startTime":"0","endTime":"0","summary":"Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.12) per share. This is a 76 percent increase over losses of $(0.50) per share from the same period last year.  The company reported $30.202 million in sales this","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/09/47956160/nanobiotix-h1-eps-0-12-up-from-0-50-yoy-sales-30-202m-up-from-10-001m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Nanobiotix H1 EPS $(0.12) Up From $(0.50) YoY, Sales $30.202M Up From $10.001M YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ",".IXIC","QID","NVIW.SI","QLD","USJW.SI","TQQQ","MNQmain","TSYW.SI","NQmain","NBTX","BK4139","PSQ","USAW.SI"],"gpt_icon":0},{"id":"2572601371","title":"Press Release: NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2572601371","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572601371?lang=en_us&edition=fundamental","pubTime":"2025-10-01 04:15","pubTimestamp":1759263300,"startTime":"0","endTime":"0","summary":"PARIS and CAMBRIDGE, Mass., Sept. 30, 2025  -- NANOBIOTIX , a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, provided an update on operational progress and announced its half year financial results for the six-month period ended June 30, 2025.Operational Highlights of the 2025 Half Year Period and To Date. Expanding clinical development program evaluating the potential broad applicability of JNJ-1900  continues to build significant momentum:. -- First patient dosed in the CONVERGE study, a Johnson & Johnson. for patients with Stage 3 unresectable non-small cell lung cancer. receiving standard of care chemoradiation followed by consolidation. -- First data announced from the completed dose escalation part of a Phase 1. study evaluating JNJ-1900  as a 2L+ therapy for patients with. locally advanced NSCLC, sponsored by the University of Texas MD Anderson. evaluating JNJ-19","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","BK4007","LU1221951129.SGD","LU2112291526.USD","SG9999002224.SGD","LU1914381329.SGD","BK4559","IE00BLSP4452.SGD","BK4534","LU2471134879.HKD","LU1732800096.USD","NBTX","IE00BLSP4239.USD","LU0985320562.USD","LU1244550221.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0466842654.USD","LU2430703178.SGD","LU0234572021.USD","LU1430594728.SGD","LU2129689431.USD","IE00B19Z3B42.SGD","IE00BFXG1179.USD","LU1061106388.HKD","LU1506573853.SGD","LU1674673691.USD","LU1894683348.USD","JNJ","LU1059921491.USD","LU1674673428.USD","LU1074936037.SGD","LU1221951046.USD","LU0114720955.EUR","IE0034235303.USD","LU2430703095.HKD","LU1066053197.SGD","LU2430703251.USD","LU0795875086.SGD","LU1244550577.SGD","IE00BGHQF631.EUR","IE00BBT3K403.USD","BK4581","LU0792757196.USD","LU1585245621.USD","IE00BFTCPJ56.SGD","IE00B3T34201.USD","LU1732799900.SGD","LU1280957306.USD","LU2347655156.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}]}}